User Fee Draft Suggests Congressional Wariness Of Trump Budget
Discussion draft includes US FDA negotiated user fee amounts well short of the total in recent Trump budget outline.
You may also be interested in...
House and Senate release discussion draft of user fee reauthorization legislation that does not include any additional policy or practice changes for US FDA, though they may arrive later.
To enhance combination product reviews, drug fee revenue will pay for related positions in CDRH.
Final year of this user fee cycle will include 14% discount, but agency says it is ready for revenue reduction.